Human CD19 Monoclonal Antibody (N297Q)
Produktgrößen
1 mg
£268,00
YR0502-1MG
5 mg
£746,00
YR0502-5MG
20 mg
£1442,00
YR0502-20MG
Über dieses Produkt
- SKU:
- YR0502
- Zusätzliche Namen:
- B4|CVID3
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab shows antitumor activity and has potential application in non-Hodgkin's lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL).
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- CD19
- Isotyp:
- IgG1, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0502